Department of Biology, Faculty of Education, Nile Valley University, P.O. Box 1843, Atbara, Sudan.
Vaccine. 2013 Oct 1;31(42):4775-81. doi: 10.1016/j.vaccine.2013.08.004. Epub 2013 Aug 14.
Malignant ovine theileriosis caused by Theileria lestoquardi is an economically important disease infecting small ruminants in the Sudan. The disease causes massive losses among sheep in many regions of Northern Sudan. The present studies were done to isolate lymphoblastoid cells infected with malignant ovine theileriosis and attenuate them by passage using culture media to develop and produce schizonts candidate vaccine, then test its efficacy and safety by exposing immunized lambs to field challenge in an area endemic with T. lestoquardi. In the present experiments we isolated and established an in vitro culture of T. lestoquardi infected lymphoblast cell line. Long-term culture of T. lestoquardi infected lymphoplastoid cells was shown to result in attenuation of their virulence and lambs inoculated with different doses of such cells at passage 105 exhibited very mild reactions with fever that lasted for 1-5 days and parasitaemia of <0.2%. The experimental lambs immunized with this candidate vaccine were immune and protected when exposed to field challenge in an area endemic of ovine theileriosis, while morbidity and mortality among non-immunized animals reached 76.9% and 46.15%, respectively, and they exhibited the clinical signs of malignant ovine theileriosis that included, high fever, loss of appetite, enlargement of lymph nodes, jaundice, loss of weight and death. The present study demonstrates the efficacy and the safety of this attenuated cell line as a live attenuated candidate vaccine.
由莱斯特氏泰勒虫引起的恶性绵羊泰勒虫病是一种在苏丹感染小反刍动物的具有经济重要性的疾病。该疾病在苏丹北部的许多地区给绵羊造成了巨大的损失。本研究旨在分离感染恶性绵羊泰勒虫的淋巴母细胞系,并通过传代使用培养基使其减毒,从而开发和生产裂殖子候选疫苗,然后通过在流行莱斯特氏泰勒虫的地区对免疫羔羊进行现场挑战来测试其功效和安全性。在本实验中,我们分离并建立了感染莱斯特氏泰勒虫的淋巴母细胞系的体外培养。证明长期培养感染的淋巴母细胞系会导致其毒力减弱,在传代 105 时接种不同剂量此类细胞的羔羊仅表现出轻微的发热反应,持续 1-5 天,寄生虫血症<0.2%。用这种候选疫苗免疫的实验羔羊在流行绵羊泰勒虫病的地区进行现场挑战时具有免疫力和保护力,而未免疫动物的发病率和死亡率分别达到 76.9%和 46.15%,并表现出恶性绵羊泰勒虫病的临床症状,包括高热、食欲不振、淋巴结肿大、黄疸、体重减轻和死亡。本研究证明了这种减毒细胞系作为活减毒候选疫苗的功效和安全性。